Rise and shine, everyone, another busy day is on the way. This will be an especially hectic day, in fact, thanks to a flurry of news about everyone’s favorite topic — the cost of medicines. Besides a speech from President Trump, which you can read about below, we will be quarterbacking a discussion today. So time to fire up the coffee kettle and get cracking. Here is the menu of tidbits to help you get started. Hope all goes well today and you conquer the world. And, as always, do keep in touch …

President Trump on Thursday will unveil a plan to overhaul how Medicare pays for certain drugs, attacking “foreign freeloaders” that he says have driven up costs in the U.S., Politico reports. The speech, which comes just days before the tightly contested midterm elections, follows two major drug-pricing headline wins, STAT notes. One is a proposal to force drug makers to include list prices in TV ads, and then there is a new law that bans so-called gag clauses, which prevent pharmacists from telling customers when it’s cheaper to pay cash for a drug rather than using insurance.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • The dependence of the “research-based pharmaceutical industry” on pricing, rather than new drug development, to drive growth reminds me of the old W. C. Fields line, “Once, during Prohibition, I was forced to live for days on nothing but food and water.”

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy